Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Aug 15:7:34.
doi: 10.1186/1471-230X-7-34.

Portal vein thrombosis; risk factors, clinical presentation and treatment

Kirstine K Sogaard  1 , Lone B Astrup, Hendrik Vilstrup, Henning Gronbaek
Affiliations

Portal vein thrombosis; risk factors, clinical presentation and treatment

Kirstine K Sogaard et al. BMC Gastroenterol. .

Abstract

Background: Portal vein thrombosis (PVT) is increasingly frequently being diagnosed, but systematic descriptions of the natural history and clinical handling of the condition are sparse. The aim of this retrospective study was to describe risk factors, clinical presentation, complications and treatment of portal vein thrombosis in a single-centre.

Methods: Sixty-seven patients were identified in the electronic records from 1992 to 2005. All data were obtained from the patient records.

Results: One or more risk factors (e.g. prothrombotic disorder or abdominal inflammation) were present in 87%. Symptoms were abdominalia, splenomegaly, fever, ascites, haematemesis, and weight loss. Abdominalia and fever occurred more frequently in patients with acute PVT. Frequent complications were splenomegaly, oesophageal- and gastric varices with or without bleeding, portal hypertensive gastropathy and ascites. Varices and bleeding were more frequent in patients with chronic PVT. Patients who received anticoagulant therapy more frequently achieved partial/complete recanalization. Patients with varices who were treated endoscopically in combination with beta-blockade had regression of the varices. The overall mortality was 13% in one year, and was dependent on underlying causes.

Conclusion: Most patients had a combination of local and systemic risk factors for PVT. We observed that partial/complete recanalization was more frequent in patients treated with anticoagulation therapy, and that regression of varices was more pronounced in patients who where treated with active endoscopy combined with pharmacological treatment.

PubMed Disclaimer

References

    1. Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol. 2006;12:2115–2119. - PMC - PubMed
    1. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736–741. doi: 10.1016/j.jhep.2004.01.001. - DOI - PubMed
    1. Orloff MJ, Orloff MS, Orloff SL, Girard B. Portal Vein Thrombosis in Cirrhosis With Variceal Hemorrhage. J Gastrointest Surg. 1997;1:123–131.2. doi: 10.1016/S1091-255X(97)80099-6. - DOI - PubMed
    1. Malkowski P, Pawlak J, Michalowicz B, Szczerban J, Wroblewski T, Leowska E, Krawczyk M. Thrombolytic treatment of portal thrombosis. Hepatogastroenterology. 2003;50:2098–2100. - PubMed
    1. Condat B, Pessione F, Helene DM, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32:466–470. doi: 10.1053/jhep.2000.16597. - DOI - PubMed

MeSH terms